The Global Market for HPV Associated Disorders, 2018-2023 and 2024-2033, Featuring Profiles of Leading Players AstraZeneca, Roche, Biocon, GlaxoSmithKline, and Merck & Co

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "HPV Associated Disorders Global Market Report 2024" report has been added to ResearchAndMarkets.coms offering.The global HPV associated disorders market has grown strongly in recent years. It will grow from $19.42 billion in 2023 to $20.97 billion in 2024 at a compound annual growth rate (CAGR) of 8%. The expansion during the historical period can be ascribed to the increasing prevalence of HPV-associated disorders, a heightened awareness of HP...